Lexaria Bioscience Corp. Quarterly Operating Lease, Right-of-Use Asset in USD from Q3 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Lexaria Bioscience Corp. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q3 2019 to Q2 2024.
  • Lexaria Bioscience Corp. Operating Lease, Right-of-Use Asset for the quarter ending May 31, 2024 was $143K.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $143K May 31, 2024 10-Q 2024-07-12
Q1 2024 $150K Feb 29, 2024 10-Q 2024-04-09
Q3 2023 $167K Aug 31, 2023 10-Q 2024-07-12
Q2 2022 $62.4K -$37.9K -37.8% May 31, 2022 10-Q 2022-07-14
Q1 2022 $72.1K -$37.2K -34% Feb 28, 2022 10-Q 2022-04-11
Q4 2021 $81.7K -$36.5K -30.9% Nov 30, 2021 10-Q 2022-01-14
Q3 2021 $91K -$35.9K -28.3% Aug 31, 2021 10-Q 2022-07-14
Q2 2021 $100K May 31, 2021 10-Q 2021-07-15
Q1 2021 $109K Feb 28, 2021 10-Q 2021-04-14
Q4 2020 $118K Nov 30, 2020 10-Q 2021-01-14
Q3 2020 $127K -$33.4K -20.8% Aug 31, 2020 10-Q 2021-07-15
Q3 2019 $160K Sep 1, 2019 10-K 2021-11-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.